Alcon, CH0432492467

The Systane Ultra Lubricant Eye Drops. Dry-eye care with a long shelf presence

Published on 07/21/2026 at 21:45 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Systane Ultra Lubricant Eye Drops, a long-established dry eye solution, target burning and irritation with a polymer-based lubricant system. Anyone holding Alcon Inc. stock (ISIN CH0432492467) should know this product.

Extreme macro photography of a human eye, wide horizontal crop. Iris filling frame with fine fibrous radial texture, golden-green coloration with brown flecks, dark limbal ring, eyelashes framing top edge, razor-thin depth of field, pin-sharp focus
Alcon CH0432492467: Extreme Makro Nahaufnahme einer grĂĽnen Iris mit fasriger Textur und langen Wimpern, Illustration mit AI erstellt.

Systane Ultra Lubricant Eye Drops land on the bathroom shelf in a slim, cool plastic bottle that clicks lightly when you twist the cap. One or two drops, and users like optometrist Dr. Karen Walsh describe a smooth, slightly viscous film spreading across the eye surface.

Polymer formula for dry eyes

Alcon positions Systane Ultra as a lubricant eye drop for temporary relief of burning and irritation due to dryness of the eye, using a combination of polyethylene glycol 400 and propylene glycol as active ingredients. Alcon product information These drops rely on Alcon’s proprietary HP-Guar gelling technology, which interacts with the tear film to increase residence time on the ocular surface. Clinical review of Systane Ultra

Formulated as a sterile solution, Systane Ultra contains preservatives such as polyquaternium-1 to maintain microbiological stability in multi-dose bottles, a trade-off that suits many consumers but makes the product less ideal for frequent, long-term use in post-operative patients. Rx monograph for Systane Ultra The solution is clear and slightly thicker than water, designed to spread quickly without significant blurring for most users.

Dig deeper & contextualize

Alcon Inc. and its dry-eye portfolio

Systane Ultra sits in a broad lubricant and dry-eye product family that influences Alcon Inc.’s recurring revenue profile.

Positioning in the Systane family

Systane Ultra sits between classic lubricating drops and more intensive options such as Systane Complete, targeting mild to moderate dry eye symptoms in a wide consumer base. Systane dry-eye overview Brand director Maria Costa has described the Systane portfolio as a tiered approach: Ultra for everyday relief, Balance and Complete for lipid layer issues, and Hydration variants for extended comfort.

In pharmacies and mass retail, Systane Ultra is often stocked in small 10 ml bottles and larger 15 ml presentations, with a per-unit price that typically aligns with branded lubricant drops rather than discount generics. Retail listing example The brand benefits from strong visibility on eye-care shelves alongside contact lens solutions, a synergy Alcon actively cultivates.

How consumers use Systane Ultra

Clinical studies have evaluated Systane Ultra in patients with dry eye disease, confirming improvements in tear film stability and symptom scores over periods of weeks. PubMed study on Systane Ultra Eye-care professionals like Dr. Walsh typically recommend one to two drops as needed, up to several times per day, with caution about overuse in patients sensitive to preservatives.

Users often report a brief cool sensation followed by a lubricating layer that reduces burning and foreign-body feeling. For screen-heavy office workers, Systane Ultra tends to be used episodically rather than on a fixed schedule, sitting beside a mug of coffee and a keyboard, ready for afternoon dryness.

Regulatory and market footprint

Systane Ultra Lubricant Eye Drops are marketed as an over-the-counter product in major markets including the United States and the European Union, typically classified as an OTC drug or medical device depending on local regulation. Regulatory filing reference Alcon’s Systane line is manufactured under sterile conditions, with quality requirements aligned to ophthalmic drug standards.

Pricing and reimbursement differ by region. In Germany, for example, Systane Ultra is sold through pharmacies and online retailers, generally not reimbursed by statutory health insurance for standard dry-eye complaints, which pushes competition with lower-cost generics and private-label lubricants.

Impact on Alcon’s business

Alcon generates recurring revenue from its dry eye and ocular health segment, where Systane Ultra represents a stable, mature product that still attracts new users as screen time and aging populations drive demand. CEO David Endicott often highlights ocular health and dry-eye management as key growth areas alongside surgical devices and contact lenses in investor presentations. Alcon investor commentary

For retail investors, the Alcon Inc. share (ISIN CH0432492467) reflects, among other segments, the ongoing contribution of branded OTC products like Systane Ultra to the company’s cash flow and brand equity.

Key facts about Systane Ultra Lubricant Eye Drops

  • Product: Systane Ultra Lubricant Eye Drops
  • Manufacturer: Alcon Inc.
  • Category: Novelty/Launch (eye care OTC drug)
  • Market launch: Mid-2000s, following HP-Guar-based dry-eye formulations
  • MSRP / Price: Around 10–15 USD for a 10 ml bottle in the US market
  • Availability: Widely available OTC in pharmacies, drugstores and online retailers in North America and Europe
  • Target group: Adults with mild to moderate dry eye symptoms, including contact lens wearers when lenses are removed
  • Highlight / USP: HP-Guar-based lubricant system that forms a gelling layer on the eye surface for longer relief compared with simple saline drops

Find Systane Ultra in social media

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | CH0432492467 | ALCON | boerse | 69827473 |